WELCOME
Novati Investments, LLC provides seed funding and Series B Investments in early stage companies and
co-invests with venture funds in later stage companies developing therapeutics and medical devices in diseases primarily affecting women and children.
Our Portfolio
Office Address:
870 Martin Luther King, Jr. Blvd
Chapel Hill, NC 27514
Zumatek is a breast imaging company specializing in the development of leading edge 3D dedicated imaging technologies for enhanced lesion detection.
Dorsan™ is a renewable bioproducts company developing a platform technology that is capable of producing advanced biofuels and chemicals from agricultural, municipal, and industrial waste materials.
Chaperone Therapeutics, Inc. is an early-phase pharmaceutical company founded to develop therapies for diseases associated with protein misfolding by restoring the body's natural balance of the protein folding activity.
InnerOptic's patented 3D visualization and guidance Spotlight and AIM software makes ultrasound-guided procedures simpler and safer to perform.
Inspiration is focused on developing innovative recombinant blood coagulation factor products to fundamentally change the treatment of hemophilia.
Asklepios ("AskBio") is a biotechnology company engaged in the development and delivery of novel protein and cellular based therapies through design of proprietary Biological Nano ParticlesTM ("BNP").
Arbovax focuses on the research and development of a unique and proprietary technology that can be used to make vaccines against the worldwide threat of arthropod-borne diseases.
A world leader in pediatric cardiology, NuMED develops, manufactures, and delivers innovative cardiovascular medical products for the smallest of patients to adults with heart defects.
Recent News
NanoCor Therapeutics, Inc. is a biotechnology company focused on developing novel molecular therapies for patients with cardiovascular disease.
Focused on the human vascular system, Entegrion is developing hemostatic technologies for wound management, tissue repair, and control of hemorrhage.
